Back to the main directory
Press Release
- Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025 by GlobeNewsWire
- Omada Health to Present Real-World Evidence at ObesityWeek 2025 Demonstrating Enhanced Outcomes for Current and Former GLP-1 Users by GlobeNewsWire
- Bald Hill Antimony Project Under Option From Globex Indicates Potential for 2.7 M Tonnes at 3% to 4% Sb by GlobeNewsWire
- ESSO S.A.F. : Assemblée Générale Mixte d’Esso S.A.F. du 4 novembre 2025 by GlobeNewsWire
- Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, Therapeutics, Genetic, and Drug Information by GlobeNewsWire
- Umicore - Déclaration de transparence par Silchester International Investors LLP by GlobeNewsWire
- Transaction in Own Shares by GlobeNewsWire
- Correction: RUBIS: Activité du T3 et des 9 mois de 2025 - Nouveau trimestre de croissance des marges - Exécution opérationnelle solide by GlobeNewsWire
- CSW Industrials Completes Previously Announced Accretive, Complementary, and Synergistic Acquisition of Motors & Armatures Parts by GlobeNewsWire
- Sprott Inc. Announces 33% Dividend Increase and Declares Third Quarter 2025 Dividend by GlobeNewsWire
- HII REMUS UUV Marks 18 Years Serving Australia, and Continues to Lead Globally as Unmanned Undersea Vehicle of Choice by GlobeNewsWire
- Andrew Peller Limited Announces Third Quarter Fiscal 2026 Dividend by GlobeNewsWire
- Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update by GlobeNewsWire
- Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update by GlobeNewsWire
- Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life Extended anti-IL-23 Antibody by GlobeNewsWire
- Cardiff Oncology to Participate in Two Upcoming Investor Conferences by GlobeNewsWire
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
- Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
- Flywire Reports Third Quarter 2025 Financial Results by GlobeNewsWire
- Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent by GlobeNewsWire
- Grocery Outlet Holding Corp. Announces Third Quarter Fiscal 2025 Financial Results by GlobeNewsWire
- Mercury Systems Reports First Quarter Fiscal 2026 Results by GlobeNewsWire
- Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results by GlobeNewsWire
- Kratos Reports Third Quarter 2025 Financial Results by GlobeNewsWire
- Supernus Announces Third Quarter 2025 Financial Results by GlobeNewsWire